Paper Details

  1. Home
  2. Paper Details

A comparative study of daily and twice-weekly continuation regimens of tuberculosis chemotherapy, including a comparison of two durations of sanatorium treatment. 1. First report: the results at 12 months.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

A study of tuberculosis patients compared two different treatment regimens after 3 months of standard treatment. Both regimens, daily isoniazid plus PAS and twice-weekly streptomycin plus high-dose isoniazid, were highly effective after one year. The twice-weekly regimen was easier to manage and preferred by patients. Extending sanatorium treatment from 3 months to 6 months did not improve outcomes. The study concluded that both regimens were effective, but the twice-weekly regimen offers advantages in terms of logistics and patient satisfaction.
Paper Details　
Original Abstract of the Article :
The results of a controlled clinical trial of tuberculosis chemotherapeutic regimens, carried out with the co-operation of all 7 tuberculosis hospitals and 27 of the 30 chest clinics of the Central Bohemian region and 6 of the 10 chest clinics of Prague, are presented.Patients in whom pulmonary tube...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427959/

データ提供：米国国立医学図書館（NLM）

A Comparative Study of Tuberculosis Chemotherapy

We are diving deep into the desert of tuberculosis research, a field where scientists are constantly searching for oases of effective treatments. This study explores the effectiveness of different tuberculosis chemotherapy regimens, a topic as vast as the Sahara itself. The researchers used a controlled clinical trial, a rigorous approach akin to navigating a carefully planned desert expedition, to compare daily and twice-weekly continuation chemotherapy regimens. They also investigated the impact of sanatorium treatment duration on patient outcomes. Their findings suggest that the twice-weekly regimen, while offering administrative advantages, is equally effective and more acceptable to patients. This discovery is a beacon of hope in the fight against this ancient foe.

Twice-Weekly Regimen: A More Effective Approach?

The twice-weekly regimen, organized with meticulous detail, seems to be a winner. It offers greater convenience for patients, making it easier to adhere to the treatment plan. This finding is significant because treatment adherence is crucial in the fight against tuberculosis, akin to ensuring your camel caravan stays on course in a vast desert.

Navigating the Desert of Tuberculosis Treatment

The researchers found that the duration of sanatorium treatment didn't significantly impact the outcome, meaning that the duration of sanatorium treatment doesn't hold the key to a quick recovery. However, this doesn't mean sanatorium treatment is not important. It's still a vital part of tuberculosis treatment. Think of it as a desert oasis, offering respite and support for patients during their journey back to health.

Dr.Camel's Conclusion

This study offers a valuable insight into the effectiveness of different tuberculosis chemotherapy regimens. The twice-weekly regimen, with its convenience and effectiveness, might be the oasis we've been searching for in this challenging desert. Further research will help us refine our knowledge and continue to improve the lives of those affected by this disease.

Date :
  1. Date Completed 1972-06-15
  2. Date Revised 2018-11-13
Further Info :

Pubmed ID

4947492

DOI: Digital Object Identifier

PMC2427959

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.